Agilon Health
92 hedge funds and large institutions have $13.3B invested in Agilon Health in 2021 Q2 according to their latest regulatory filings, with 92 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
1,687% more call options, than puts
Call options by funds: $8.56M | Put options by funds: $479K
3.38% more ownership
Funds ownership: 0% → 3.38% (+3.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CDR
Clayton Dubilier & Rice
New York
|
+$7.87B |
| 2 |
Capital World Investors
Los Angeles,
California
|
+$998M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$526M |
| 4 |
Morgan Stanley
New York
|
+$272M |
| 5 |
BlackRock
New York
|
+$261M |
Top Sellers
AGL Hedge Fund Activity: Q2 2021 in Review
92 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Agilon Health (AGL) for Q2 2021, worth a combined $13.3B.
Buyers outnumbered sellers: 92 funds opened new AGL positions and 0 closed out — a net gain of 92 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Clayton Dubilier & Rice, opening a new position worth an estimated $7.87B.
- 92 institutional investors held Agilon Health (AGL) as of Q2 2021, up from 0 in Q1 2021.
- Funds reported $13.3B of Agilon Health stock for Q2 2021.
- 92 funds opened new Agilon Health positions in Q2 2021 and 0 closed out, a net change of +92 holders.
- The largest Agilon Health buyer in Q2 2021 was Clayton Dubilier & Rice, an estimated $7.87B added.
Based on aggregated 13F filings for Q2 2021.